Frederick Johan Raal

机构：University of the Witwatersrand, Philadelphia University · ORCID：0000-0002-9170-7938

发表论文 550 篇 · 总被引 38029 次 · h-index 72

代表论文

• Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial (2025 · The Lancet Diabetes & Endocrinology · 被引 22)
• Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement (2026 · European Heart Journal · 被引 16)
• Recent advances in research and care of familial hypercholesterolaemia (2025 · The Lancet Diabetes & Endocrinology · 被引 15)
• The evolving therapeutic landscape of PCSK9 inhibition (2026 · Atherosclerosis · 被引 6)
• Evinacumab in patients aged 5–17 years with homozygous familial hypercholesterolemia (2025 · Atherosclerosis · 被引 4)
• Liver transplantation in severe homozygous familial hypercholesterolaemia: a scoping review (2026 · Atherosclerosis · 被引 3)